The Street’s Key Stock Analysts Research Reports

The Street’s Key Stock Analysts Research Reports

$ABX, $BJ, $BX, $CADE, $CNI, $CENT, $CLH, $CLX, $LDC, $MCHP, $NITE

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of the Street’s Key analysts outlook for main issues for Wednesday, as follows:

Barrick Gold Corp. (NYSE:ABX) was raised to Buy from Neutral with a 14 price target at Citigroup. Shares trade in a 52-wk range of 9.53 to 16.84 and with a consensus target price at 14.04.

BJ’s Wholesale (NYSE:BJ) was started with a Buy rating and assigned a 38 price target at Northcoast. The 52-wk trading range is 20.56 – 32.92, and the consensus target price is at 28.83.

Blackstone Group L.P. (NYSE:BX) was reiterated as Buy and the price target was raised to 46 from 39 at Argus. Citigroup reiterated it as Buy and raised its price target to 47 from 43.

Cadence Bancorporation (NYSE:CADE) was started as Equal Weight and assigned a 30 price target at Morgan Stanley.

Canadian National Railway (NYSE:CNI) was raised to Buy from Neutral with a 100 price target at Citigroup. Shares trade in a 52-wk range of 70.59 – 90.57. The consensus target price is at 91.44.

Central Garden & Pet Co. (NASDAQ:CENT) analysts started as Neutral at JPMorgan. The 52-wk trading range is 34.81 – 45.02, and the consensus target price is 47.33.

Clean Harbors Inc. (NYSE:CLH) was reiterated as Buy and the target price was raised to 80 from 70 at Stifel.

Clorox Co. (NYSE:CLX) was raised to Buy from Hold with a 175 price target at Argus.

Landec Corp. (NASDAQ:LDC) was started as Buy and assigned an 18 price target at Roth Capital.

Microchip Technology Inc. (NASDAQ:MCHP) was started as Sector Weight at KeyBanc Capital Markets, and Raymond James downgraded it to Market Perform from Outperform. Shares trade in a 52-wk range of 78.33 – 104.20. The consensus target price was last seen at 113.31.

Nightstar Therapeutics Inc. (NASDAQ: NITE) analysts reiterated as Outperform and the price target was raised to 36 from 31 at Wedbush Securities.

Stay tuned…

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH